Human-in-the-Loop Design for AI Clinical Decision Support
The short answer
Human-in-the-loop design for clinical decision support means a qualified clinician can see why the AI made a recommendation, independently review the basis for it, and is clearly accountable for the final decision. Under FDA guidance, the ability of a professional to independently review the basis of a recommendation is one of the criteria that can affect whether software is regulated as a device.
Why oversight has to be designed, not assumed
Putting a clinician 'in the loop' is not enough if the interface encourages rubber-stamping. Effective oversight depends on what the reviewer sees, how much time they have, and whether disagreeing with the AI is easy and recorded.
Levels of AI involvement
| Level | AI role | Typical oversight |
|---|---|---|
| Inform | Summarises or surfaces information | Clinician reviews source on demand |
| Suggest | Proposes a draft (e.g. note, code, order) | Clinician edits and signs |
| Flag | Highlights risk or priority | Clinician confirms or dismisses with reason |
| Act | Executes without prior review | Rarely appropriate for patient-facing decisions |
Design checklist
- Show the inputs and sources behind each recommendation, not just the output.
- Make accept, edit, and reject equally easy, and capture the reason for overrides.
- Define which roles may act on each recommendation type.
- Monitor override rates and outcomes to detect automation bias or model drift.
- Assess the FDA device question and intended use with regulatory counsel early.
- Train clinicians on known limitations and when not to rely on the tool.
Start with documentation workflows
Ambient documentation and draft summaries are popular starting points because the clinician already reviews and signs the output. They build trust and oversight habits before moving closer to diagnostic or treatment decisions.
Frequently asked questions
What is human-in-the-loop AI in healthcare?
It is a design where a qualified person reviews, can override, and is accountable for AI outputs before they affect patient care, with the interface and workflow built to make that review meaningful.
Is clinical decision support software regulated by the FDA?
Some is and some is not. FDA's Clinical Decision Support Software guidance sets out criteria, including whether a professional can independently review the basis for a recommendation. Each product's intended use must be assessed.
What is automation bias?
Automation bias is the tendency to over-trust automated recommendations. Tracking override rates and showing sources helps detect and reduce it.
Where should health systems start with clinical AI?
Lower-risk workflows such as documentation drafts and chart summarisation, where clinicians already review and sign the output, are common first steps.
Official sources
- FDA: Clinical Decision Support Software Guidance
- NIST AI Risk Management Framework (AI RMF 1.0)
- NIST AI 600-1: Generative AI Profile
This article is general information, not legal or regulatory advice. Confirm how these rules apply to your organisation with your compliance team or counsel.